High prevalence of hypertension and target organ damage in patients with 11β-hydroxylase deficiency.

Bang SunLin LuYinjie GaoBingqing YuShi ChenAnli TongXueyan WuJiang-Feng MaoXi WangZhiyuan ZhaoWei ZhangMin Nie

Published in: Clinical endocrinology (2022)

Hypertension and HMOD are prevalent in patients with 11β-OHD in our study. These findings illustrate the importance of early HMOD evaluation and optimal glucocorticoid medication in 11β-OHD patients.

Keyphrases

blood pressure
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
prognostic factors
peritoneal dialysis
oxidative stress
emergency department
replacement therapy
smoking cessation